Cancer clinical trials and, in general, cancer clinical research are, by definition, multi-modal disciplines. It is not enough to discover and register new drugs. Getting cancer under control, or even better, curing it, requires researchers to perform complex clinical studies that integrate drugs, companion diagnostics, new or improved surgical procedures, and new approaches to radiotherapy.